SPRO
- Spero Therapeutics, Inc.
()
Overview
Company Summary
Spero Therapeutics, Inc. (SPRO) is a biopharmaceutical company that focuses on developing and commercializing innovative therapies to address unmet needs in the treatment of infectious diseases. The company is dedicated to developing novel antibiotics and other treatments to combat drug-resistant bacterial infections, which have become a significant public health concern globally.
SPRO is involved in identifying and developing potential drugs that can overcome the antibiotic resistance problem caused by certain bacteria, commonly known as superbugs. These drug-resistant bacteria have become increasingly resilient to existing antibiotic treatments, posing a serious threat to the effectiveness of traditional antibiotics and patient health.
The company utilizes a platform called the Potentiator Program, designed to enhance the potency of existing antibiotics against drug-resistant bacteria. This platform identifies molecules that can restore the efficacy of established antibiotics, potentially providing a new lease of life to these drugs in combating infections.
Spero Therapeutics also focuses on developing novel antibiotics through its Antibacterial Selection Platform, which identifies and optimizes compounds with the potential to treat drug-resistant infections. Through this platform, the company aims to address both gram-positive and gram-negative bacteria, which are responsible for various infectious diseases.
Apart from its antibiotic development pipeline, SPRO also engages in collaborations to leverage its expertise and resources while advancing its mission. This includes partnerships with academic institutions, government organizations, and other biopharmaceutical companies.
In summary, Spero Therapeutics, Inc. is dedicated to developing innovative therapies, particularly antibiotics, to combat drug-resistant bacterial infections. By utilizing their platform technologies and collaborating with other entities, they aim to address the urgent need for effective treatments against emerging infectious diseases caused by superbugs.